DrugPatentWatch Database Preview
Profile for Japan Patent: 4912309
US Patent Family Members and Approved Drugs for Japan Patent: 4912309
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Apr 14, 2023 | Janssen Prods | EDURANT | rilpivirine hydrochloride |
➤ Try a Free Trial | Apr 21, 2025 | Gilead Sciences Inc | COMPLERA | emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate |
➤ Try a Free Trial | Apr 21, 2025 | Janssen Prods | EDURANT | rilpivirine hydrochloride |
➤ Try a Free Trial | Apr 21, 2025 | Viiv Hlthcare | JULUCA | dolutegravir sodium; rilpivirine hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |